Carlos Enrique Toro Gutiérrez
Carlos Enrique Toro Gutiérrez publishes mostly in Rheumatology, Epidemiology and Pathology and Forensic Medicine, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Sclerosis and Related Diseases and SARS-CoV-2 and COVID-19 Research.
- World rank
- #1,865,349 of 7,710,434 ranked researchers
- Rank in Colombia
- #1,415 of 23,024
- Works
- 75
- Citations
- 498
- Citations per work
- 6.6
What does Carlos Enrique Toro Gutiérrez research?
Carlos Enrique Toro Gutiérrez's work is mostly in Medicine (65%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4864.6%
- Medicine4864.6%
- Everything else2735.4%
- 1Rheumatology22% of their works
- 2Epidemiology11% of their works
- 3Pathology and Forensic Medicine11% of their works
- 4Infectious Diseases10% of their works
- 5Pulmonary and Respiratory Medicine8% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Sclerosis and Related Diseases
- SARS-CoV-2 and COVID-19 Research
- Systemic Lupus Erythematosus Research
- Inflammatory Myopathies and Dermatomyositis
- Vasculitis and related conditions
- Musculoskeletal Disorders and Rehabilitation
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Which keywords describe Carlos Enrique Toro Gutiérrez's research?
The keywords of their largest research topics: Autoantibodies, Treatment, Fibrosis, Inflammation, Rheumatoid Arthritis, Interstitial Lung Disease, Pulmonary Involvement and Systemic Sclerosis.
- TGF-ß
- Vasculitides
- Medical Education
- Inflammatory Myopathies
- Systemic Lupus Erythematosus
- Coronavirus
- Systemic Sclerosis
- Interstitial Lung Disease
- Inflammation
- Treatment
- Autoantibodies
- Fibrosis
- Rheumatoid Arthritis
- Pulmonary Involvement
- Antiphospholipid Syndrome
- SARS-CoV-2
- Dermatomyositis
- ANCA-associated
- Musculoskeletal Medicine
- Idiopathic Pulmonary Fibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Autoantibodies684 topics
- Treatment312 topics
- Fibrosis242 topics
- Inflammation211 topic
- Rheumatoid Arthritis211 topic
- Interstitial Lung Disease192 topics
- Pulmonary Involvement181 topic
- Systemic Sclerosis181 topic
- Antiphospholipid Syndrome161 topic
- Coronavirus161 topic
- SARS-CoV-2161 topic
- Systemic Lupus Erythematosus161 topic
- Dermatomyositis131 topic
- Inflammatory Myopathies131 topic
- ANCA-associated71 topic
- Medical Education71 topic
- Musculoskeletal Medicine71 topic
- Vasculitides71 topic
- Idiopathic Pulmonary Fibrosis61 topic
- TGF-ß61 topic
Where does Carlos Enrique Toro Gutiérrez work?
Carlos Enrique Toro Gutiérrez's main affiliation in the publication record is Pontificia Universidad Javeriana, Colombia.
How many publications and citations does Carlos Enrique Toro Gutiérrez have?
OpenAlex counts 75 works and 498 citations for Carlos Enrique Toro Gutiérrez, an h-index of 10, ranking #1,865,349 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carlos Enrique Toro Gutiérrez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.